Medtronic's shareholders overwhelmingly approve its $43 billion merger with Covidien, setting the stage for the deal to close in a few weeks.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zR8ok8
Cap comentari:
Publica un comentari a l'entrada